Humana Raises 2026 Adjusted EPS Guidance to At Least $9.50
Humana raised its 2026 adjusted EPS floor to $9.50 from $9 and lifted GAAP guidance to $15.09 from $6.52, even as third-quarter adjusted results swung to a $104 million pre-tax loss.
Topic
Medicare
Topic
Medicare
Medicare's Competitive Bidding Plan Cuts Catheter Suppliers to 10
Medicare will cut hydrophilic catheter suppliers to 10 and ostomy suppliers to six from 2028, a bidding plan critics say will dis…
Hospital Stocks Surge Up to 13.4% as Democratic Wave Reshapes Healthcare
Community Health Systems jumped 13.4% after the Democratic sweep, as analysts expect Medicaid cuts reversed and ACA subsidies res…
Whoop's $10.1 Billion Bet: Wearables Chase Medicare Money
Whoop, valued at $10.1 billion, is courting Medicare recipients after the FDA dropped enforcement against its blood pressure feat…
Quest Diagnostics Falls 5.1% as CMS Moves to Cut Lab Payments Up to 15%
Quest Diagnostics dropped 5.1% after CMS said it will cut lab reimbursement rates by up to 15% starting in 2027, saving taxpayers…
Lilly Claims 70% of 700,000 New Medicare GLP-1 Seniors
Eli Lilly CEO Dave Ricks says 700,000 seniors started GLP-1s since July's Medicare coverage launch — and 70% of them are on Lilly…